Tuesday, March 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

EPA Awards $46.7M Contract to BioSeek for ToxCast Program

by Global Biodefense Staff
October 8, 2012

The U.S. Environmental Protection Agency (EPA) last week awarded a five-year contract to BioSeek, Inc., to research and evaluate the potential human health effects of substances such as environmental chemicals, pesticides, failed pharmaceuticals, and nanomaterials.

Under the contract, BioSeek will analyze up to 60,000 samples to determine the potential toxicity effects on the human body. Rather than testing the substances on animals, tests will be conducted on extracted human cells cultures utilizing the company’s BioMAP assay technology.

Work is being performed by BioSeek under U.S. EPA’s ToxCast program, which seeks to verify “toxicity signatures” of substances, such as environmental chemicals, and catalog them to help predict adverse effects these chemicals would have on the human body.

EPA researchers have published a number of papers showing how ToxCast can be used to predict a chemical’s potential for liver toxicity, developmental toxicity, reproductive toxicity and cancer.

“Our efforts are providing EPA with important information relevant to the potential human health effects associated with exposure to a wide range of environmental and other compounds,” said Ellen Berg, Ph.D., General Manager of BioSeek. “Additionally, this work will expand the BioMAP reference database with a wealth of new information for mining with our pharmaceutical partners to help understand their compounds’ safety and activity in the context of human biology, prior to entering costly clinical trials.”

EPA will additionally use BioSeek’s findings to screen thousands of chemicals to see if they require additional investigation. The contract is worth up to $46.7 million over the five-year duration.

Tags: AwardsNanotech

Related Posts

small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.
Policy + Initiatives

Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.

December 7, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC